The ABPI Code: more to come in 2009
December 15, 2008Medical Communications, Sales and Marketing ABPI, code, marketing
Is UK pharma coping with the revised Code and what changes will 2009 bring?
Preparing for the US generics boom
December 15, 2008Sales and Marketing US, generics
One of Barack Obama's key goals as president is to reduce healthcare costs, particularly those related to prescription medications, by …
Sanofi appoints new finance head
December 11, 2008Sales and Marketing Sanofi, restructure
Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …
The Pharmafocus Interview: Shadow health minister Mark Simmonds
December 11, 2008Conservatives, hc
The Conservatives have led in the opinion polls throughout 2008, and even with Gordon Brown’s rating enjoying a bounce over …
PCT funding to set to rise
December 11, 2008NHS, primary
NHS Primary Care Trusts are to receive funding worth £164 billion in the financial years 2009-10 and 2010-11. This includes …
Stroke awareness campaign planned
December 11, 2008Medical Communications stroke
A three-year campaign to raise awareness of stroke will begin in February, using a mixture of advertising, PR and direct …
College Hill to promote Abraxis ‘nanoparticle’ drug
December 10, 2008Medical Communications Abraxis, College Hill
Abraxis Bioscience has appointed PR agency College Hill to promote its cancer drug Abraxane in Europe. The albumin-bound 'nano-particle' chemotherapeutic …
Ark’s groundbreaking gene therapy filed in Europe
December 9, 2008Sales and Marketing Ark, Cerepro
Cerepro, Ark's gene-based therapy for the brain cancer malignant glioma, has been filed with the European medicines agency. The drug …
UK biotech seeks bail out
December 9, 2008Research and Development biotech
Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …
PRA International expands European presence
December 9, 2008Medical Communications Germany, PRA
Contract research organisation PRA International has opened a new office in Munich, its third base in Germany. Several major pharmaceutical …
Efficacy or effectiveness?
December 9, 2008Research and Development Les Rose, clinical trials, evidence
The question of ‘generalisability’ – or the extent clinical trials can be applied to the real world, has been an …
Caution: you are entering phase III
December 8, 2008Research and Development clinical trials, drug development, phase III
Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …
Cytotoxic therapies to feel sting of generics
December 8, 2008Sales and Marketing generics
Cytotoxic therapy has been the cornerstone of cancer treatment for many years: indeed, despite a number of unpleasant side effects, …
SMC criticises PPRS prescribing incentives
December 5, 2008Sales and Marketing NICE, par
The government move to incentivise doctors for the prescription of new innovative medicines has been criticised by the Scottish Medicines …
Rawlins could stay on at NICE
December 4, 2008NICE
Prof Sir Michael Rawlins could be set to extend his tenure as chairman of NICE, with the government prepared to …
New Pegasys licence gives patients ‘second chance for a cure’
December 4, 2008Sales and Marketing Roche, hepatitis
Hepatitis C patients who don't at first respond to treatment with Pegasys will now be able to receive the drug …
Patients use NICE to challenge doctors
December 4, 2008Sales and Marketing NICE
Patients are increasingly holding doctors to account by bringing NICE guidance with them to consultations. Debate at NICE's annual conference …
Pharma could be top performer in recession, says AZ chief
December 4, 2008Sales and Marketing AZ, hc
AstraZeneca's chief executive David Brennan says the pharmaceutical industry could be one of the top performing sectors during the global …
Latest content
